Yvonne K. Jongejan, MSc

PhD candidate
Department of Internal Medicine, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Leiden, Zuid-Holland, Netherlands

Yvonne Jongejan joined the group of Prof. Jeroen Eikenboom in the Department of Internal Medicine, Division of Thrombosis and Hemostasis of the Leiden University Medical Center on March 1, 2019 as a PhD student. Her project is co-supervised by Dr. Bart van Vlijmen. She holds a BSc degree in Biomedical Sciences and a MSc degree in Pharmaceutical Sciences (Drug Innovation), both from Utrecht University. Her PhD project focuses on the inhibition of von Willebrand factor to reduce arterial thrombosis risk, using RNA targeted therapies.

Presentation(s):

• OC 08.5 - Allele-selective inhibition of mutant von Willebrand factor with small interfering RNAs to ameliorate a von Willebrand disease type 2B phenotype in vivo in mice

  Saturday, June 24, 2023
  14:00 – 14:15 ET

• PB1431 - Effect of allele-selective silencing of von Willebrand factor in mice on experimental bleeding and thrombosis models

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1432 - Small interfering RNA-mediated inhibition of endothelial von Willebrand factor in pro-atherothrombotic mice

  Tuesday, June 27, 2023
  18:30 – 19:30 ET